Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schussler

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
JAMA Surgery|November 14, 2019
A Consensus Framework for the Humanitarian Surgical Response to Armed Conflict in 21st Century WarfareSherry M Wren, Hannah B Wild, Jennifer Gurney, et al.
The American Journal of Cardiology|January 22, 2025
Comparative Outcomes of Left Main and Nonleft Main Percutaneous Coronary Intervention from the Excellence in Coronary Artery Disease (XLCAD) RegistryRobert C Stoler, Minseob Jeong, Talha Akram, et al.
Glia|November 15, 2017
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse modelsMartine Latta-Mahieu, Bradford Elmer, Alexis Bretteville, et al.
The Journal of Experimental Medicine|March 24, 2026
DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responsesIsabelle K Vila, Yasmine Messaoud-Nacer, Clara Taffoni, et al.
JCO Precision Oncology|June 29, 2023
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER CollaborationChristine N Bailey, Brian J Martin, Valentina I Petkov, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
JNCI Cancer Spectrum|August 1, 2023
Use of the Decipher genomic classifier among men with prostate cancer in the United StatesNicholas G Zaorsky, James A Proudfoot, Angela Y Jia, et al.
The Lancet. Oncology|June 14, 2015
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA TrialsAimée R Kreimer, Frank Struyf, Maria Rowena Del Rosario-Raymundo, et al.
Science Translational Medicine|September 18, 2024
A deep intronic splice-altering <i>AIRE</i> variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusionSebastian Ochoa, Amy P Hsu, Andrew J Oler, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
JAMA Surgery|November 14, 2019
A Consensus Framework for the Humanitarian Surgical Response to Armed Conflict in 21st Century WarfareSherry M Wren, Hannah B Wild, Jennifer Gurney, et al.
The American Journal of Cardiology|January 22, 2025
Comparative Outcomes of Left Main and Nonleft Main Percutaneous Coronary Intervention from the Excellence in Coronary Artery Disease (XLCAD) RegistryRobert C Stoler, Minseob Jeong, Talha Akram, et al.
Glia|November 15, 2017
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse modelsMartine Latta-Mahieu, Bradford Elmer, Alexis Bretteville, et al.
The Journal of Experimental Medicine|March 24, 2026
DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responsesIsabelle K Vila, Yasmine Messaoud-Nacer, Clara Taffoni, et al.
JCO Precision Oncology|June 29, 2023
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER CollaborationChristine N Bailey, Brian J Martin, Valentina I Petkov, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
JNCI Cancer Spectrum|August 1, 2023
Use of the Decipher genomic classifier among men with prostate cancer in the United StatesNicholas G Zaorsky, James A Proudfoot, Angela Y Jia, et al.
The Lancet. Oncology|June 14, 2015
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA TrialsAimée R Kreimer, Frank Struyf, Maria Rowena Del Rosario-Raymundo, et al.
Science Translational Medicine|September 18, 2024
A deep intronic splice-altering <i>AIRE</i> variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusionSebastian Ochoa, Amy P Hsu, Andrew J Oler, et al.
Pageof 37